Tuesday
SESSION 11: MORE LOWER EXTREMITY HOT TOPICS – NEW STENT AND DRUG ELUTING BALLOON (DEB) DATA; IMPACT AND COST ISSUES
Moderators:Joseph L. Mills, MD / Giancarlo Biamino, MD, PhD  
SESSION 11 SCHEDULE
8:38 AM - 8:43 AM Is There A Negative Effect Of Endovascular Failure On Bypass Outcomes: Is It Reality Or A Myth
  Presenter(s):Michael S. Conte, MD  
  View Abstract      
8:44 AM - 8:49 AM What Is The Effect Of Extensive Lesion Calcification On The Outcome Of DEB Treatment
  Presenter(s):Gunnar Tepe, MD  
  View Abstract      
8:50 AM - 8:55 AM Why Are DEBs Cost Effective For Treating CLI Patients
  Presenter(s):Thomas Zeller, MD  
  View Abstract      
8:56 AM - 9:01 AM How To Align Financial Incentives For The Doctor, The Hospital And The Payer (Insurance Company) To Provide The Best And Most Effective Care In The Least Costly Manner: Impact Of Expensive New Technologies And Reintervention Rates
  Presenter(s):W. Charles Sternbergh III, MD  
  View Abstract      
9:02 AM - 9:07 AM Tips And Tricks For Tibial Interventions For CLI
  Presenter(s):Roberto Ferraresi, MD  
  View Abstract      
9:08 AM - 9:13 AM What’s New With US Approved Drug Eluting Stents (DESs) In The SFA And Below
  Presenter(s):Ron Waksman, MD  
  View Abstract      
9:14 AM - 9:19 AM 5-Year Results And New Findings From The Zilver PTX RCT And Registry: Benefits Of DESs Are Durable And Value With In Stent Restenosis (ISR), Long Lesions And Diabetics
  Presenter(s):Michael D. Dake, MD  
  View Abstract      
9:20 AM - 9:25 AM 2-3-Year Results With EverFlex Helical Nitinol Stent In The SFA And The Popliteal Artery: Are The Benefits Durable
  Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD  
  View Abstract      
9:25 AM - 9:33 AM Panel Discussion
9:33 AM - 9:48 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 11
previous next